Q4JHS0
Gene name |
BID |
Protein name |
BH3-interacting domain death agonist |
Names |
p22 BID , BID [Cleaved into: BH3-interacting domain death agonist p15 , p15 BID; BH3-interacting domain death agonist p13 , p13 BID; BH3-interacting domain death agonist p11 , p11 BID] |
Species |
Sus scrofa (Pig) |
KEGG Pathway |
ssc:594852 |
EC number |
|
Protein Class |
|
Descriptions
Autoinhibitory domains (AIDs)
Target domain |
83-99 (BH3 domain) |
Relief mechanism |
Cleavage |
Assay |
|
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
2 structures for Q4JHS0
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| 5UA4 | X-ray | 260 A | B | 73-106 | PDB |
| AF-Q4JHS0-F1 | Predicted | AlphaFoldDB |
5 variants for Q4JHS0
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| rs700956925 | 15 | R>C | No | EVA | |
| rs788609921 | 68 | A>S | No | EVA | |
| rs697649085 | 76 | Q>E | No | EVA | |
| rs321037631 | 86 | H>Q | No | EVA | |
| rs700739156 | 124 | L>M | No | EVA |
No associated diseases with Q4JHS0
No regional properties for Q4JHS0
| Type | Name | Position | InterPro Accession |
|---|---|---|---|
| No domain, repeats, and functional sites for Q4JHS0 | |||
3 GO annotations of cellular component
| Name | Definition |
|---|---|
| cytosol | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. |
| mitochondrial outer membrane | The outer, i.e. cytoplasm-facing, lipid bilayer of the mitochondrial envelope. |
| mitochondrion | A semiautonomous, self replicating organelle that occurs in varying numbers, shapes, and sizes in the cytoplasm of virtually all eukaryotic cells. It is notably the site of tissue respiration. |
No GO annotations of molecular function
| Name | Definition |
|---|---|
| No GO annotations for molecular function |
5 GO annotations of biological process
| Name | Definition |
|---|---|
| apoptotic mitochondrial changes | The morphological and physiological alterations undergone by mitochondria during apoptosis. |
| hepatocyte apoptotic process | Any apoptotic process in a hepatocyte, the main structural component of the liver. |
| positive regulation of extrinsic apoptotic signaling pathway | Any process that activates or increases the frequency, rate or extent of extrinsic apoptotic signaling pathway. |
| positive regulation of intrinsic apoptotic signaling pathway | Any process that activates or increases the frequency, rate or extent of intrinsic apoptotic signaling pathway. |
| positive regulation of release of cytochrome c from mitochondria | Any process that increases the rate, frequency or extent of release of cytochrome c from mitochondria, the process in which cytochrome c is enabled to move from the mitochondrial intermembrane space into the cytosol, which is an early step in apoptosis and leads to caspase activation. |
3 homologous proteins in AiPD
| 10 | 20 | 30 | 40 | 50 | 60 |
| MDSKVSNGSS | LQDERITNLL | VFGFLQSCPH | ASFHKELEVL | GHELPVHTSG | SDELQTDGNR |
| 70 | 80 | 90 | 100 | 110 | 120 |
| CSYFMEDAAE | TDSESQEAVI | RDIARHLARI | GDRMEYGIRP | GLVDSLAAQF | RNQSLSEEDR |
| 130 | 140 | 150 | 160 | 170 | 180 |
| RQGLAAVLQQ | LVHSYPADMG | QEKTLLVLTM | LLARKVAEHS | PALLRDVFHT | TVNFINQNLL |
| 190 | |||||
| TYLRNLVQSE | MD |